Ildong Pharmaceutical Co., Ltd.

Equities

A249420

KR7249420001

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-22 pm EDT			5-day change	1st Jan Change
14,780 ^KRW	-0.34%		-0.81%	-18.61%

2023	Il Dong Pharmaceutical Eyes Approval for to Manufacture Japan's COVID-19 Treatment in South Korea	MT
2023	Il Dong Pharmaceutical Introduces New R&D Unit Yunovia	MT

Ildong Pharmaceutical Co., Ltd. announced that it has received KRW 100 billion in funding

January 27, 2021

On January 28, 2021, Ildong Pharmaceutical Co., Ltd. (KOSE:A249420) closed the transaction.

Latest news about Ildong Pharmaceutical Co., Ltd.

Il Dong Pharmaceutical Eyes Approval for to Manufacture Japan's COVID-19 Treatment in South Korea	Dec. 29	MT
Il Dong Pharmaceutical Introduces New R&D Unit Yunovia	Nov. 06	MT
Ildong Pharmaceutical Co., Ltd. announced that it has received KRW 30 billion in funding	23-10-19	CI
Ildong Pharmaceutical Co., Ltd. announced that it expects to receive KRW 30 billion in funding	23-10-17	CI
Ildong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Il Dong's Application for Shionogi's COVID Oral Medication Accepted for Review in South Korea	23-01-04	MT
Ildong Pharmaceutical Co., Ltd. Files a New Drug Application with the MFDS for the Indication of SARS-CoV-2 Infection, and This Application Has Been Accepted for Review by MFDS	23-01-03	CI
Shionogi JV Sub-licenses COVID-19 Drug to South Korea's Il Dong Pharmaceutical	22-09-19	MT
Twist Bioscience, Ildong Pharmaceutical Partner to Discover Antibodies for Immuno-Oncology	22-06-30	MT
Twist Bioscience Corporation and Ildong Pharmaceutical Enter into Collaboration to Enhance Antibody Discovery for Applications in Immuno-Oncology	22-06-30	CI
South Korean Pharmaceutical Firms Rush to Develop COVID-19 Oral Pills	21-12-29	MT
Il Dong Pharmaceutical Starts Clinical Trial of COVID-19 Drug	21-11-29	MT
Ildong Pharmaceutical Starts Phase 1 Study of New Diabetes Therapy in Germany	21-07-01	CI
Ildong Pharmaceutical Co., Ltd. announced that it has received KRW 100 billion in funding	21-01-27	CI
Ildong Pharmaceutical Co., Ltd. announced that it expects to receive KRW 100 billion in funding	21-01-17	CI
Evotec SE and Ildong to Collaborate with Development Projects on Indigo Platform	20-03-31	CI
Ildong Pharmaceutical Co., Ltd. Enters into Co-Promotion Agreement with GSK Consumer Healthcare SA	19-12-04	CI
Ildong Holdings Co., Ltd. acquired 5.18% stake in Ildong Pharmaceutical Co., Ltd. from Il-dong Foods Co. Ltd. and Lee, Keumki for KRW 22.4 billion.	19-02-26	CI
AntriaBio, Inc. announced that it has received $13 million in funding from Aju Pharm Co Limited, Ildong Pharmaceutical Co., Ltd., Medici Investment	17-07-16	CI
Ildong Holdings Co., Ltd. completed the acquisition of 19.25% stake in Ildong Pharmaceutical Co., Ltd. for KRW 65.4 billion.	17-03-27	CI
AntriaBio, Inc. announced that it expects to receive $15 million in funding	17-03-05	CI
Ildong Holdings Co., Ltd. made a tender offer to acquire an additional 29.14% stake in Ildong Pharmaceutical Co., Ltd. for KRW 98.9 billion.	17-02-05	CI
Ildong Pharmaceutical Co., Ltd. completed the Spin-Off of its pharmaceutical business division for KRW 518.3 billion.	16-07-31	CI
Ildong Pharmaceutical Co., Ltd. agreed to spin-off its pharmaceutical business division.	16-03-08	CI
Ildong Holdings Co., Ltd. cancelled the Spin-Off of Ildong Pharmaceutical Co., Ltd..	14-01-24	CI

Chart Ildong Pharmaceutical Co., Ltd.

Duration

Period

More charts

Company Profile

IL DONG PHARMACEUTICAL CO., LTD. is a Korea-based company mainly engaged in the manufacture of pharmaceuticals.

Sector

Pharmaceuticals

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ILDONG PHARMACEUTICAL CO., LTD.	-18.61%	300M
ELI LILLY AND COMPANY	+27.92%	659B
NOVO NORDISK A/S	+27.68%	557B
JOHNSON & JOHNSON	-4.59%	359B
MERCK & CO., INC.	+16.38%	322B
ABBVIE INC.	+9.39%	297B
ASTRAZENECA PLC	+6.30%	215B
NOVARTIS AG	+4.80%	210B
ROCHE HOLDING AG	-6.05%	200B
PFIZER, INC.	-8.58%	149B

Other Pharmaceuticals

Ildong Pharmaceutical Co., Ltd.

Equities

A249420

KR7249420001

Pharmaceuticals

Ildong Pharmaceutical Co., Ltd. announced that it has received KRW 100 billion in funding

Latest news about Ildong Pharmaceutical Co., Ltd.

Chart Ildong Pharmaceutical Co., Ltd.

Company Profile

Income Statement Evolution

EPS Revisions

Annual profits - Rate of surprise

Sector Other Pharmaceuticals